Science (AAAS) and Institute of Food Technologists (IFT).
d. Demian Barbas B.Sc., Ph.D., has particular expertise in biochemistry,
biotechnology, intellectual property law and patents in life sciences.
Dr. Barbas is currently practising at Ogilvy Renault LLP/S.E.N.C.R.L.,
s.r.l., and is a member of the American Society for Biochemistry and
Molecular Biology (ASBMB) and an affiliate of the Intellectual
Property Institute of Canada (IPIC).
e. Melvin Dionne B.Sc. Pharm., has been the president of Services
Pharmaceutiques Melvin Dionne Inc since 1999. He has a strong
background in regulatory affairs and quality control in the
pharmaceutical industry, with particular expertise in pharmaceutical
company compliance with Health Canada and FDA regulations for product
and site licensing.
"I feel extremely honoured to be working with such an eminent group of scientists and profiting from their guidance and valuable advice while developing and building our product pipeline and growing in the nutraceutical and pharmaceutical worlds" said Dr. Tina Sampalis, Vice-President Research and Business Development of Neptune.
About Neptune Technologies & Bioressources Inc.
Neptune Technologies & Bioressources Inc. develops proprietary and
potent health ingredients from underexploited marine biomasses, such as
krill, with its patented extraction process (Neptune OceanExtract(TM)).
Using its proprietary process, Neptune Technologies & Bioressources Inc. is
strategically positioning itself in the nutraceutical and pharmaceutical
health and wellness market. The Company develops and markets new formulas
and new products for specific applications in high growth markets such the
nutraceutical, cosmeceutical, biopharmaceutical and nutrigenomics markets,
the next wave in nutritional research. Through strategic alliances and
partnerships, as well as through cli
|SOURCE NEPTUNE TECHNOLOGIES & BIORESSOURCES INC.|
Copyright©2007 PR Newswire.
All rights reserved